{"chunk_id": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)__chunk_31", "source": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)", "text": "tion \npresented in the Risk Summary and Clinical \nConsiderations headings \n•Human Data \n•Animal Data \n \nFDA/CDER/OND/ODEIV/DPMH \n8.2 Lactation \n \n• Three headings: \n– Risk Summary* \n– Clinical \nConsiderations \n– Data \nFDA/CDER/OND/ODEIV/DPMH 31 \n*Required heading \n32 \n8.2 Lactation- Risk Summary*  \n• No drug systemic absorption \n \n“[TRADENAME] is not absorbed systemically by the \nmother following (route of administration) and \nbreastfeeding is not expected to result in exposure of \nthe infant to"}